DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Cadila Pharmaceuticals Limited
03 2Cipla Ltd.
04 1Divi's Laboratories Limited
05 1Glenmark Life Sciences Limited
06 1MSD International GmbH (Singapore Branch)
07 1MYLAN LABORATORIES LIMITED
08 1Morepen Laboratories Limited
09 1Tianish Laboratories Private Limited
10 1Vasudha Pharma Chem Limited
01 3DESLORATADINE
02 7Desloratadine
03 1desloratadine
01 9India
02 2U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-073
Start Marketing Date : 2006-05-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65691-0057
Start Marketing Date : 2007-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7613
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7688
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-019
Start Marketing Date : 2004-11-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-830
Start Marketing Date : 2006-05-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 75895-0099
Start Marketing Date : 2001-12-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62993-0805
Start Marketing Date : 2004-08-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66577-018
Start Marketing Date : 2006-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 65015-698
Start Marketing Date : 2015-01-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Desloratadine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Desloratadine, including repackagers and relabelers. The FDA regulates Desloratadine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Desloratadine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Desloratadine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Desloratadine supplier is an individual or a company that provides Desloratadine active pharmaceutical ingredient (API) or Desloratadine finished formulations upon request. The Desloratadine suppliers may include Desloratadine API manufacturers, exporters, distributors and traders.
click here to find a list of Desloratadine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Desloratadine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Desloratadine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Desloratadine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Desloratadine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Desloratadine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Desloratadine suppliers with NDC on PharmaCompass.
We have 10 companies offering Desloratadine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
